Skip to main content
Journal cover image

Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.

Publication ,  Journal Article
Bassand, J-P; Afzal, R; Eikelboom, J; Wallentin, L; Peters, R; Budaj, A; Fox, KAA; Joyner, CD; Chrolavicius, S; Granger, CB; Mehta, S ...
Published in: Eur Heart J
January 2010

AIMS: In patients with acute coronary syndromes (ACS), the negative impact of baseline haemoglobin levels on ischaemic events, particularly death, is well established, but the association with bleeding risk is less well studied. The aim of this study was to assess the impact of baseline haemoglobin levels on major bleeding complications. METHODS AND RESULTS: Pooled analysis of OASIS 5 and 6 data involving 32 170 patients with ACS with and without ST-segment elevation was performed. The association between baseline haemoglobin and major bleeding or ischaemic events was examined using multiple regression model. MAIN OUTCOME MEASURES: were 30-day rates of major bleeding, death, and death/myocardial infarction (MI) analysed according to baseline haemoglobin levels. Baseline haemoglobin level independently predicted the risk of overall, procedure-related, and non-procedure-related major bleedings at 30 days [odds ratio (OR) 0.94, 95% CI 0.90-0.98; OR 0.94, 95% CI 0.90-0.99; and OR 0.89, 95% CI 0.83-0.95, respectively, per 1 g/dL haemoglobin increment above 10 g/dL]. In addition, a curvilinear relationship between baseline haemoglobin levels and death at 30 days was observed with a 6% decrease in the risk for every 1 g/dL haemoglobin increment above 10 g/dL up to 15.9 g/dL (OR 0.94, 95% CI 0.90-0.98) and a 19% increase above this value (OR 1.19, 95% CI, 0.98-1.43). A similar relationship for the composite outcome of death/MI was observed. CONCLUSION: A low baseline haemoglobin level is an independent predictor of the risk of major bleeding in ACS as well as of the risk of death and death and MI. Among other predictors of bleeding risk, baseline haemoglobin should be taken into account in patients presenting with ACS. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov number, NCT00139815. http://clinicaltrials.gov/ct2/show/NCT00139815?term=NCT00139815&rank=1.

Duke Scholars

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

January 2010

Volume

31

Issue

1

Start / End Page

50 / 58

Location

England

Related Subject Headings

  • Treatment Outcome
  • Polysaccharides
  • Middle Aged
  • Male
  • Humans
  • Heparin
  • Hemorrhage
  • Hemoglobins
  • Fondaparinux
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bassand, J.-P., Afzal, R., Eikelboom, J., Wallentin, L., Peters, R., Budaj, A., … OASIS 5 and OASIS 6 Investigators, . (2010). Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J, 31(1), 50–58. https://doi.org/10.1093/eurheartj/ehp401
Bassand, Jean-Pierre, Rizwan Afzal, John Eikelboom, Lars Wallentin, Ron Peters, Andrzej Budaj, Keith A. A. Fox, et al. “Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.Eur Heart J 31, no. 1 (January 2010): 50–58. https://doi.org/10.1093/eurheartj/ehp401.
Bassand J-P, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, et al. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J. 2010 Jan;31(1):50–8.
Bassand, Jean-Pierre, et al. “Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.Eur Heart J, vol. 31, no. 1, Jan. 2010, pp. 50–58. Pubmed, doi:10.1093/eurheartj/ehp401.
Bassand J-P, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, Fox KAA, Joyner CD, Chrolavicius S, Granger CB, Mehta S, Yusuf S, OASIS 5 and OASIS 6 Investigators. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J. 2010 Jan;31(1):50–58.
Journal cover image

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

January 2010

Volume

31

Issue

1

Start / End Page

50 / 58

Location

England

Related Subject Headings

  • Treatment Outcome
  • Polysaccharides
  • Middle Aged
  • Male
  • Humans
  • Heparin
  • Hemorrhage
  • Hemoglobins
  • Fondaparinux
  • Female